Logo image of KAVL

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

NASDAQ:KAVL - Nasdaq - US4831044023 - Common Stock - Currency: USD

0.606  +0 (+0.33%)

After market: 0.5815 -0.02 (-4.04%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KAVL. KAVL was compared to 18 industry peers in the Distributors industry. The financial health of KAVL is average, but there are quite some concerns on its profitability. KAVL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KAVL had negative earnings in the past year.
In the past year KAVL has reported a negative cash flow from operations.
In the past 5 years KAVL reported 4 times negative net income.
KAVL had negative operating cash flow in 4 of the past 5 years.
KAVL Yearly Net Income VS EBIT VS OCF VS FCFKAVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -63.05%, KAVL is doing worse than 88.89% of the companies in the same industry.
Looking at the Return On Equity, with a value of -70.20%, KAVL is doing worse than 72.22% of the companies in the same industry.
Industry RankSector Rank
ROA -63.05%
ROE -70.2%
ROIC N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
KAVL Yearly ROA, ROE, ROICKAVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

KAVL's Gross Margin of 41.52% is fine compared to the rest of the industry. KAVL outperforms 77.78% of its industry peers.
KAVL's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for KAVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
KAVL Yearly Profit, Operating, Gross MarginsKAVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KAVL has more shares outstanding
The number of shares outstanding for KAVL has been increased compared to 5 years ago.
KAVL has a better debt/assets ratio than last year.
KAVL Yearly Shares OutstandingKAVL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
KAVL Yearly Total Debt VS Total AssetsKAVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

KAVL has an Altman-Z score of -2.66. This is a bad value and indicates that KAVL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.66, KAVL is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.00 indicates that KAVL is not too dependend on debt financing.
The Debt to Equity ratio of KAVL (0.00) is better than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.66
ROIC/WACCN/A
WACC14.72%
KAVL Yearly LT Debt VS Equity VS FCFKAVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.42 indicates that KAVL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.42, KAVL is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
A Quick Ratio of 3.42 indicates that KAVL has no problem at all paying its short term obligations.
KAVL has a better Quick ratio (3.42) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
KAVL Yearly Current Assets VS Current LiabilitesKAVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.25% over the past year.
The Revenue for KAVL has decreased by -71.85% in the past year. This is quite bad
KAVL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -51.07% yearly.
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)-71.85%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-93.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KAVL Yearly Revenue VS EstimatesKAVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
KAVL Yearly EPS VS EstimatesKAVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KAVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KAVL Price Earnings VS Forward Price EarningsKAVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KAVL Per share dataKAVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KAVL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (5/22/2025, 8:19:13 PM)

After market: 0.5815 -0.02 (-4.04%)

0.606

+0 (+0.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)03-17 2025-03-17
Earnings (Next)06-16 2025-06-16
Inst Owners1.5%
Inst Owner Change13.77%
Ins Owners20.24%
Ins Owner Change0%
Market Cap6.99M
Analysts82.86
Price TargetN/A
Short Float %0.1%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.8
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.34
BVpS1.1
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.05%
ROE -70.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.52%
FCFM N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z -2.66
F-Score5
WACC14.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-71.85%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-93.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.62%
OCF growth 3YN/A
OCF growth 5YN/A